As CtBP activity is directly correlated with the stoichiometric availability of cellular NAD (11), we determined whether NAMPT inhibition, which has been used as a strategy for cellular NAD depletion in a number of tumor types (5, 22, 23), can effectively lower NAD levels in PDAC cells. This evidence concerns the gene CTBP1 and neoplasm.